nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP4F2—trachea—esophageal cancer	0.0167	0.0644	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—esophageal cancer	0.0161	0.0622	CbGeAlD
Fingolimod—S1PR4—lung—esophageal cancer	0.0152	0.0587	CbGeAlD
Fingolimod—Posterior reversible encephalopathy syndrome—Cisplatin—esophageal cancer	0.0149	0.101	CcSEcCtD
Fingolimod—S1PR1—epithelium—esophageal cancer	0.0147	0.0569	CbGeAlD
Fingolimod—SPHK1—bronchus—esophageal cancer	0.0144	0.0555	CbGeAlD
Fingolimod—CYP4F2—digestive system—esophageal cancer	0.0143	0.0554	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—esophageal cancer	0.0142	0.0548	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—esophageal cancer	0.0141	0.0543	CbGeAlD
Fingolimod—CYP4F12—bronchus—esophageal cancer	0.0138	0.0533	CbGeAlD
Fingolimod—SPHK1—trachea—esophageal cancer	0.0129	0.0498	CbGeAlD
Fingolimod—CYP4F12—trachea—esophageal cancer	0.0124	0.0478	CbGeAlD
Fingolimod—CYP4F12—digestive system—esophageal cancer	0.0107	0.0412	CbGeAlD
Fingolimod—S1PR3—lung—esophageal cancer	0.0106	0.041	CbGeAlD
Fingolimod—S1PR4—lymph node—esophageal cancer	0.0104	0.0402	CbGeAlD
Fingolimod—X-linked lymphoproliferative syndrome—Methotrexate—esophageal cancer	0.00991	0.0671	CcSEcCtD
Fingolimod—Lymphoproliferative disorder—Methotrexate—esophageal cancer	0.00991	0.0671	CcSEcCtD
Fingolimod—S1PR1—lung—esophageal cancer	0.00937	0.0362	CbGeAlD
Fingolimod—SPHK1—lung—esophageal cancer	0.00927	0.0358	CbGeAlD
Fingolimod—CYP4F12—lung—esophageal cancer	0.00891	0.0344	CbGeAlD
Fingolimod—S1PR5—lymph node—esophageal cancer	0.00875	0.0338	CbGeAlD
Fingolimod—S1PR3—lymph node—esophageal cancer	0.00727	0.0281	CbGeAlD
Fingolimod—Herpes virus infection—Capecitabine—esophageal cancer	0.00649	0.0439	CcSEcCtD
Fingolimod—S1PR1—lymph node—esophageal cancer	0.00641	0.0247	CbGeAlD
Fingolimod—SPHK1—lymph node—esophageal cancer	0.00634	0.0245	CbGeAlD
Fingolimod—CYP4F12—lymph node—esophageal cancer	0.00609	0.0235	CbGeAlD
Fingolimod—Lower respiratory tract infection—Capecitabine—esophageal cancer	0.00527	0.0357	CcSEcCtD
Fingolimod—Depressed mood—Capecitabine—esophageal cancer	0.00403	0.0273	CcSEcCtD
Fingolimod—Lymphoma—Methotrexate—esophageal cancer	0.00384	0.026	CcSEcCtD
Fingolimod—Lymphopenia—Capecitabine—esophageal cancer	0.00352	0.0238	CcSEcCtD
Fingolimod—Visual acuity reduced—Capecitabine—esophageal cancer	0.00303	0.0205	CcSEcCtD
Fingolimod—Infection—Carboplatin—esophageal cancer	0.00295	0.02	CcSEcCtD
Fingolimod—Liver injury—Cisplatin—esophageal cancer	0.0029	0.0197	CcSEcCtD
Fingolimod—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00275	0.0186	CcSEcCtD
Fingolimod—Herpes zoster—Capecitabine—esophageal cancer	0.00239	0.0162	CcSEcCtD
Fingolimod—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00181	0.0123	CcSEcCtD
Fingolimod—CYP2E1—digestive system—esophageal cancer	0.0018	0.00694	CbGeAlD
Fingolimod—Herpes zoster—Methotrexate—esophageal cancer	0.00178	0.0121	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0016	0.0108	CcSEcCtD
Fingolimod—CYP2E1—lung—esophageal cancer	0.0015	0.0058	CbGeAlD
Fingolimod—Gastroenteritis—Capecitabine—esophageal cancer	0.00148	0.00998	CcSEcCtD
Fingolimod—Eye pain—Capecitabine—esophageal cancer	0.00145	0.0098	CcSEcCtD
Fingolimod—CYP3A4—digestive system—esophageal cancer	0.00145	0.00558	CbGeAlD
Fingolimod—CYP2D6—digestive system—esophageal cancer	0.00142	0.0055	CbGeAlD
Fingolimod—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00142	0.00959	CcSEcCtD
Fingolimod—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00133	0.00903	CcSEcCtD
Fingolimod—Migraine—Capecitabine—esophageal cancer	0.00129	0.00871	CcSEcCtD
Fingolimod—Bradycardia—Cisplatin—esophageal cancer	0.00125	0.00845	CcSEcCtD
Fingolimod—Cardiac arrest—Capecitabine—esophageal cancer	0.00124	0.00841	CcSEcCtD
Fingolimod—Liver function test abnormal—Capecitabine—esophageal cancer	0.00121	0.00817	CcSEcCtD
Fingolimod—Connective tissue disorder—Cisplatin—esophageal cancer	0.00121	0.00816	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00118	0.00797	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00115	0.00781	CcSEcCtD
Fingolimod—Eye disorder—Cisplatin—esophageal cancer	0.00115	0.00776	CcSEcCtD
Fingolimod—Cardiac disorder—Cisplatin—esophageal cancer	0.00114	0.00771	CcSEcCtD
Fingolimod—Influenza—Capecitabine—esophageal cancer	0.00113	0.00765	CcSEcCtD
Fingolimod—Mediastinal disorder—Cisplatin—esophageal cancer	0.00111	0.00749	CcSEcCtD
Fingolimod—Bronchitis—Capecitabine—esophageal cancer	0.00109	0.00736	CcSEcCtD
Fingolimod—Alopecia—Cisplatin—esophageal cancer	0.00108	0.00734	CcSEcCtD
Fingolimod—Weight decreased—Capecitabine—esophageal cancer	0.00102	0.00692	CcSEcCtD
Fingolimod—Pneumonia—Capecitabine—esophageal cancer	0.00101	0.00686	CcSEcCtD
Fingolimod—Infestation NOS—Capecitabine—esophageal cancer	0.00101	0.00682	CcSEcCtD
Fingolimod—Infestation—Capecitabine—esophageal cancer	0.00101	0.00682	CcSEcCtD
Fingolimod—Vision blurred—Cisplatin—esophageal cancer	0.00101	0.00681	CcSEcCtD
Fingolimod—Depression—Capecitabine—esophageal cancer	0.001	0.0068	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000993	0.00672	CcSEcCtD
Fingolimod—Leukopenia—Cisplatin—esophageal cancer	0.000956	0.00647	CcSEcCtD
Fingolimod—Bradycardia—Capecitabine—esophageal cancer	0.000921	0.00623	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000903	0.00611	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—esophageal cancer	0.000899	0.00608	CcSEcCtD
Fingolimod—Connective tissue disorder—Capecitabine—esophageal cancer	0.000889	0.00602	CcSEcCtD
Fingolimod—Infection—Cisplatin—esophageal cancer	0.000866	0.00586	CcSEcCtD
Fingolimod—Nervous system disorder—Cisplatin—esophageal cancer	0.000855	0.00579	CcSEcCtD
Fingolimod—Skin disorder—Cisplatin—esophageal cancer	0.000847	0.00573	CcSEcCtD
Fingolimod—Eye disorder—Capecitabine—esophageal cancer	0.000845	0.00572	CcSEcCtD
Fingolimod—Cardiac disorder—Capecitabine—esophageal cancer	0.000839	0.00568	CcSEcCtD
Fingolimod—Angiopathy—Capecitabine—esophageal cancer	0.000821	0.00555	CcSEcCtD
Fingolimod—Mediastinal disorder—Capecitabine—esophageal cancer	0.000815	0.00552	CcSEcCtD
Fingolimod—Hypotension—Cisplatin—esophageal cancer	0.000815	0.00551	CcSEcCtD
Fingolimod—Alopecia—Capecitabine—esophageal cancer	0.000799	0.00541	CcSEcCtD
Fingolimod—Mental disorder—Capecitabine—esophageal cancer	0.000792	0.00536	CcSEcCtD
Fingolimod—Paraesthesia—Cisplatin—esophageal cancer	0.000783	0.0053	CcSEcCtD
Fingolimod—Dyspnoea—Cisplatin—esophageal cancer	0.000777	0.00526	CcSEcCtD
Fingolimod—Back pain—Capecitabine—esophageal cancer	0.000762	0.00516	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—esophageal cancer	0.000754	0.00511	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000753	0.00509	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—esophageal cancer	0.00075	0.00508	CcSEcCtD
Fingolimod—Infestation—Methotrexate—esophageal cancer	0.00075	0.00508	CcSEcCtD
Fingolimod—Depression—Methotrexate—esophageal cancer	0.000748	0.00506	CcSEcCtD
Fingolimod—Vision blurred—Capecitabine—esophageal cancer	0.000742	0.00502	CcSEcCtD
Fingolimod—Leukopenia—Capecitabine—esophageal cancer	0.000705	0.00477	CcSEcCtD
Fingolimod—Palpitations—Capecitabine—esophageal cancer	0.000696	0.00471	CcSEcCtD
Fingolimod—Cough—Capecitabine—esophageal cancer	0.000687	0.00465	CcSEcCtD
Fingolimod—Hypertension—Capecitabine—esophageal cancer	0.00068	0.0046	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000666	0.00451	CcSEcCtD
Fingolimod—Infection—Capecitabine—esophageal cancer	0.000638	0.00432	CcSEcCtD
Fingolimod—Nervous system disorder—Capecitabine—esophageal cancer	0.00063	0.00427	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—esophageal cancer	0.000629	0.00426	CcSEcCtD
Fingolimod—Asthenia—Cisplatin—esophageal cancer	0.000625	0.00423	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—esophageal cancer	0.000625	0.00423	CcSEcCtD
Fingolimod—Skin disorder—Capecitabine—esophageal cancer	0.000624	0.00422	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—esophageal cancer	0.000611	0.00413	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—esophageal cancer	0.000607	0.00411	CcSEcCtD
Fingolimod—Hypotension—Capecitabine—esophageal cancer	0.0006	0.00406	CcSEcCtD
Fingolimod—Diarrhoea—Cisplatin—esophageal cancer	0.000596	0.00404	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—esophageal cancer	0.000595	0.00403	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—esophageal cancer	0.00059	0.00399	CcSEcCtD
Fingolimod—Paraesthesia—Capecitabine—esophageal cancer	0.000577	0.00391	CcSEcCtD
Fingolimod—Dyspnoea—Capecitabine—esophageal cancer	0.000573	0.00388	CcSEcCtD
Fingolimod—Back pain—Methotrexate—esophageal cancer	0.000567	0.00384	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000555	0.00376	CcSEcCtD
Fingolimod—Fatigue—Capecitabine—esophageal cancer	0.000554	0.00375	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—esophageal cancer	0.000552	0.00374	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—esophageal cancer	0.000525	0.00355	CcSEcCtD
Fingolimod—Cough—Methotrexate—esophageal cancer	0.000511	0.00346	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000496	0.00335	CcSEcCtD
Fingolimod—Infection—Methotrexate—esophageal cancer	0.000475	0.00322	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—esophageal cancer	0.000469	0.00318	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—esophageal cancer	0.000465	0.00315	CcSEcCtD
Fingolimod—Asthenia—Capecitabine—esophageal cancer	0.000461	0.00312	CcSEcCtD
Fingolimod—Pruritus—Capecitabine—esophageal cancer	0.000455	0.00308	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—esophageal cancer	0.000447	0.00303	CcSEcCtD
Fingolimod—Diarrhoea—Capecitabine—esophageal cancer	0.00044	0.00298	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—esophageal cancer	0.00043	0.00291	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—esophageal cancer	0.000426	0.00289	CcSEcCtD
Fingolimod—Dizziness—Capecitabine—esophageal cancer	0.000425	0.00288	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000413	0.0028	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—esophageal cancer	0.000412	0.00279	CcSEcCtD
Fingolimod—Headache—Capecitabine—esophageal cancer	0.000403	0.00272	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—esophageal cancer	0.000343	0.00232	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—esophageal cancer	0.000338	0.00229	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—esophageal cancer	0.000327	0.00222	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—esophageal cancer	0.000316	0.00214	CcSEcCtD
Fingolimod—Headache—Methotrexate—esophageal cancer	0.0003	0.00203	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—HMOX1—esophageal cancer	0.000185	0.000311	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000182	0.000307	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000181	0.000305	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00018	0.000303	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PSME1—esophageal cancer	0.000179	0.000302	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PSME2—esophageal cancer	0.000179	0.000302	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ANXA1—esophageal cancer	0.000178	0.000301	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000177	0.000299	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000177	0.000299	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ABCB1—esophageal cancer	0.000177	0.000299	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000176	0.000296	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000175	0.000295	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFBR2—esophageal cancer	0.000174	0.000293	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP19A1—esophageal cancer	0.000174	0.000293	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SST—esophageal cancer	0.000173	0.000292	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOTCH2—esophageal cancer	0.000171	0.000289	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH3—esophageal cancer	0.000169	0.000285	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GHRL—esophageal cancer	0.000169	0.000285	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFBR2—esophageal cancer	0.000167	0.000282	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFBR2—esophageal cancer	0.000167	0.000282	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000167	0.000281	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FBXW7—esophageal cancer	0.000166	0.00028	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000166	0.00028	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000165	0.000277	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SMAD4—esophageal cancer	0.000165	0.000277	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—HMOX1—esophageal cancer	0.000159	0.000267	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SMAD4—esophageal cancer	0.000158	0.000267	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SMAD4—esophageal cancer	0.000158	0.000267	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000158	0.000266	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000156	0.000263	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000156	0.000262	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000155	0.000261	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000154	0.00026	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ABCB1—esophageal cancer	0.000152	0.000257	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000152	0.000256	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH2—esophageal cancer	0.000152	0.000256	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000148	0.00025	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000146	0.000246	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SMAD4—esophageal cancer	0.000144	0.000242	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000143	0.000242	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000141	0.000238	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CREBBP—esophageal cancer	0.000137	0.000231	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HIF1A—esophageal cancer	0.000135	0.000227	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFBR2—esophageal cancer	0.000134	0.000227	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000134	0.000226	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000133	0.000225	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000131	0.000222	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HIF1A—esophageal cancer	0.00013	0.000218	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HIF1A—esophageal cancer	0.00013	0.000218	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KDR—esophageal cancer	0.000129	0.000217	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SMAD4—esophageal cancer	0.000127	0.000215	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000126	0.000212	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000124	0.000209	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KDR—esophageal cancer	0.000124	0.000209	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KDR—esophageal cancer	0.000124	0.000209	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—NOS3—esophageal cancer	0.000123	0.000207	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOTCH1—esophageal cancer	0.000121	0.000204	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CREBBP—esophageal cancer	0.000118	0.0002	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000118	0.0002	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HIF1A—esophageal cancer	0.000118	0.000198	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000117	0.000197	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOTCH1—esophageal cancer	0.000117	0.000197	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOTCH1—esophageal cancer	0.000117	0.000197	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000115	0.000194	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KDR—esophageal cancer	0.000113	0.00019	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—esophageal cancer	0.000112	0.000189	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CREBBP—esophageal cancer	0.00011	0.000185	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000109	0.000183	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—esophageal cancer	0.000108	0.000182	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—NOS3—esophageal cancer	0.000106	0.000179	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOTCH1—esophageal cancer	0.000106	0.000179	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CREBBP—esophageal cancer	0.000106	0.000178	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CREBBP—esophageal cancer	0.000106	0.000178	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HIF1A—esophageal cancer	0.000104	0.000176	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—esophageal cancer	0.000104	0.000175	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—esophageal cancer	0.000104	0.000175	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000103	0.000174	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000103	0.000174	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000102	0.000172	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CREBBP—esophageal cancer	0.000102	0.000172	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KDR—esophageal cancer	9.96e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CA—esophageal cancer	9.94e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CA—esophageal cancer	9.94e-05	0.000168	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOS3—esophageal cancer	9.85e-05	0.000166	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—esophageal cancer	9.7e-05	0.000163	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	9.68e-05	0.000163	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CREBBP—esophageal cancer	9.61e-05	0.000162	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOS3—esophageal cancer	9.48e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOS3—esophageal cancer	9.48e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—esophageal cancer	9.45e-05	0.000159	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH1—esophageal cancer	9.38e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CA—esophageal cancer	9.38e-05	0.000158	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—EP300—esophageal cancer	9.34e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—esophageal cancer	9.21e-05	0.000155	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NOS3—esophageal cancer	9.11e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—esophageal cancer	9.03e-05	0.000152	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—esophageal cancer	9.03e-05	0.000152	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—esophageal cancer	9.03e-05	0.000152	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—BLVRB—esophageal cancer	8.97e-05	0.000151	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC52A3—esophageal cancer	8.97e-05	0.000151	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—esophageal cancer	8.87e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—esophageal cancer	8.87e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOS3—esophageal cancer	8.61e-05	0.000145	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CREBBP—esophageal cancer	8.51e-05	0.000143	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—esophageal cancer	8.33e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	8.23e-05	0.000139	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—esophageal cancer	8.2e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—esophageal cancer	8.14e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	8.12e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—EP300—esophageal cancer	8.07e-05	0.000136	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—esophageal cancer	8.05e-05	0.000136	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1A—esophageal cancer	7.87e-05	0.000133	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—esophageal cancer	7.83e-05	0.000132	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—esophageal cancer	7.83e-05	0.000132	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	7.74e-05	0.00013	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	7.63e-05	0.000129	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC10A2—esophageal cancer	7.62e-05	0.000129	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA1—esophageal cancer	7.62e-05	0.000129	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOS3—esophageal cancer	7.62e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1A—esophageal cancer	7.58e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1A—esophageal cancer	7.58e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EP300—esophageal cancer	7.49e-05	0.000126	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EP300—esophageal cancer	7.21e-05	0.000122	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EP300—esophageal cancer	7.21e-05	0.000122	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—esophageal cancer	7.12e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—esophageal cancer	7.11e-05	0.00012	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA2—esophageal cancer	6.97e-05	0.000118	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—esophageal cancer	6.93e-05	0.000117	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—esophageal cancer	6.91e-05	0.000117	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—esophageal cancer	6.88e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—esophageal cancer	6.55e-05	0.00011	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—esophageal cancer	6.53e-05	0.00011	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLCE1—esophageal cancer	6.48e-05	0.000109	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADH7—esophageal cancer	6.48e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—esophageal cancer	6.38e-05	0.000108	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC52A3—esophageal cancer	6.36e-05	0.000107	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BLVRB—esophageal cancer	6.36e-05	0.000107	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—esophageal cancer	6.29e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—esophageal cancer	6.28e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—esophageal cancer	6.28e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—esophageal cancer	6.15e-05	0.000104	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—esophageal cancer	6.15e-05	0.000104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—esophageal cancer	6.09e-05	0.000103	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—esophageal cancer	5.97e-05	0.000101	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—esophageal cancer	5.79e-05	9.77e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—esophageal cancer	5.71e-05	9.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADH1B—esophageal cancer	5.68e-05	9.58e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—esophageal cancer	5.58e-05	9.41e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—esophageal cancer	5.54e-05	9.34e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMP—esophageal cancer	5.43e-05	9.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA1—esophageal cancer	5.41e-05	9.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC10A2—esophageal cancer	5.41e-05	9.12e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—esophageal cancer	5.36e-05	9.04e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—esophageal cancer	5.33e-05	8.99e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—esophageal cancer	5.33e-05	8.99e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP26A1—esophageal cancer	5.28e-05	8.91e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—esophageal cancer	5.16e-05	8.7e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—esophageal cancer	5.16e-05	8.7e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALOX15—esophageal cancer	5.15e-05	8.68e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—esophageal cancer	5.13e-05	8.64e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—esophageal cancer	5.05e-05	8.51e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA2—esophageal cancer	4.95e-05	8.34e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—esophageal cancer	4.94e-05	8.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TPI1—esophageal cancer	4.91e-05	8.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTO1—esophageal cancer	4.91e-05	8.28e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—esophageal cancer	4.84e-05	8.16e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDOB—esophageal cancer	4.71e-05	7.94e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—esophageal cancer	4.69e-05	7.9e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLCE1—esophageal cancer	4.6e-05	7.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADH7—esophageal cancer	4.6e-05	7.75e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GAPDH—esophageal cancer	4.53e-05	7.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CRABP1—esophageal cancer	4.49e-05	7.57e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—esophageal cancer	4.29e-05	7.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNG7—esophageal cancer	4.27e-05	7.2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.16e-05	7.01e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.16e-05	7.01e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—esophageal cancer	4.15e-05	6.99e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.03e-05	6.8e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDH2—esophageal cancer	4e-05	6.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMP—esophageal cancer	3.85e-05	6.5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—esophageal cancer	3.81e-05	6.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2A6—esophageal cancer	3.77e-05	6.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.75e-05	6.32e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.65e-05	6.16e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS1—esophageal cancer	3.57e-05	6.02e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO1—esophageal cancer	3.57e-05	6.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.54e-05	5.96e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA1—esophageal cancer	3.54e-05	5.96e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSME2—esophageal cancer	3.52e-05	5.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PSME1—esophageal cancer	3.52e-05	5.93e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.49e-05	5.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TPI1—esophageal cancer	3.49e-05	5.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.34e-05	5.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA2—esophageal cancer	3.23e-05	5.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.22e-05	5.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.19e-05	5.37e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1B1—esophageal cancer	3.03e-05	5.12e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNG7—esophageal cancer	3.03e-05	5.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.01e-05	5.07e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADH7—esophageal cancer	3.01e-05	5.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP19A1—esophageal cancer	2.85e-05	4.81e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.84e-05	4.79e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.7e-05	4.56e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.67e-05	4.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.64e-05	4.45e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—esophageal cancer	2.6e-05	4.39e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO1—esophageal cancer	2.53e-05	4.27e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.53e-05	4.27e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMP—esophageal cancer	2.52e-05	4.25e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ABCB1—esophageal cancer	2.5e-05	4.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSME1—esophageal cancer	2.5e-05	4.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PSME2—esophageal cancer	2.5e-05	4.21e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.45e-05	4.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.39e-05	4.03e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TPI1—esophageal cancer	2.28e-05	3.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.28e-05	3.84e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.19e-05	3.68e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.15e-05	3.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.1e-05	3.55e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.08e-05	3.51e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.02e-05	3.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNG7—esophageal cancer	1.98e-05	3.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.86e-05	3.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.85e-05	3.11e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.77e-05	2.99e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.77e-05	2.98e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.75e-05	2.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.67e-05	2.82e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.66e-05	2.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO1—esophageal cancer	1.66e-05	2.79e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSME2—esophageal cancer	1.63e-05	2.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSME1—esophageal cancer	1.63e-05	2.75e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—esophageal cancer	1.5e-05	2.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.41e-05	2.37e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.37e-05	2.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.32e-05	2.23e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.21e-05	2.04e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.19e-05	2e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.16e-05	1.95e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—esophageal cancer	1.14e-05	1.92e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—esophageal cancer	1.06e-05	1.79e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—esophageal cancer	9.71e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—esophageal cancer	8.42e-06	1.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—esophageal cancer	8.07e-06	1.36e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CREBBP—esophageal cancer	7.75e-06	1.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—esophageal cancer	6.94e-06	1.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.35e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—esophageal cancer	5.97e-06	1.01e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—esophageal cancer	5.28e-06	8.9e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.9e-06	6.58e-06	CbGpPWpGaD
